SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A South Australian Clinical Case Series and Australian Spontaneous Adverse Event Notifications

被引：87

作者：

Meyer, Emily J. ^{[1
,2
,3
]}

Gabb, Genevieve ^{[2
,4
]}

Jesudason, David ^{[1
,2
,3
]}

机构：

[1] Royal Adelaide Hosp, Endocrine & Metab Unit, Adelaide, SA, Australia

[2] Univ Adelaide, Discipline Med, Adelaide, SA, Australia

[3] Queen Elizabeth Hosp, Dept Endocrinol & Diabet, Woodville, SA, Australia

[4] Royal Adelaide Hosp, Dept Gen Med, Adelaide, SA, Australia

来源：

DIABETES CARE | 2018年 / 41卷 / 04期

关键词：

D O I：

10.2337/dc17-1721

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E47 / E49

页数：3

共 5 条

[1] Risk of Diabetic Ketoacidosis after Initiation of an SGLT2 Inhibitor [J].

Fralick, Michael ;

Schneeweiss, Sebastian ;

Patorno, Elisabetta .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (23) :2300-2302

[2] AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS [J].

Handelsman, Yehuda ;

Henry, Robert R. ;

Bloomgarden, Zachary T. ;

Dagogo-Jack, Sam ;

DeFronzo, Ralph A. ;

Einhorn, Daniel ;

Ferrannini, Ele ;

Fonseca, Vivian A. ;

Garber, Alan J. ;

Grunberger, George ;

LeRoith, Derek ;

Umpierrez, Guillermo E. ;

Weir, Matthew R. .

ENDOCRINE PRACTICE, 2016, 22 (06) :753-762

[3] Under-reporting of adverse drug reactions - A systematic review [J].

Hazell, Lorna ;

Shakir, Saad A. W. .

DRUG SAFETY, 2006, 29 (05) :385-396

[4] Euglycaemic diabetic ketoacidosis in patients using sodium-glucose co-transporter 2 inhibitors [J].

Isaacs, Michelle ;

Tonks, Katherine T. ;

Greenfield, Jerry R. .

INTERNAL MEDICINE JOURNAL, 2017, 47 (06) :701-704

[5] Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors [J].

Rosenstock, Julio ;

Ferrannini, Ele .

DIABETES CARE, 2015, 38 (09) :1638-1642

← 1 →